The following aberrations in genes known to be implicated in tumor development were also present: CCNE1, MDM2, MITF, NFKBIA, PIK3CA amplifications, and short-variant mutations of BCORL1, CDK12, and TP53. This evidence concerns the gene TP53 and neoplasm.